TTRX – turn therapeutics inc. (US:NASDAQ)
Stock Stats
News
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
Turn Therapeutics (NASDAQ:TTRX) is now covered by analysts at Weiss Ratings. They set a "sell (e-)" rating on the stock.
Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.
Turn Therapeutics (NASDAQ:TTRX) was upgraded by analysts at D Boral Capital to a "strong-buy" rating.
Form 8-K Turn Therapeutics Inc. For: Jan 12
Form 8-K Turn Therapeutics Inc. For: Jan 07
Form 4 Turn Therapeutics Inc. For: Dec 12 Filed by: Chaudhary Zuraiz
Form 4 Turn Therapeutics Inc. For: Nov 24 Filed by: GOLDEN ARTHUR F
Form 4 Turn Therapeutics Inc. For: Nov 21 Filed by: GOLDEN ARTHUR F
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.